Q3304841 (Q3304841): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in en: Setting new description)
(‎Created claim: summary (P836): Development of an integrated workflow for the identification of immune-relevant mutations, synthesis of derived peptides and clinical use of the corresponding neoantigens for novel immunisation strategies in colon and pancreas tumors., translated_summary)
Property / summary
 
Development of an integrated workflow for the identification of immune-relevant mutations, synthesis of derived peptides and clinical use of the corresponding neoantigens for novel immunisation strategies in colon and pancreas tumors. (English)
Property / summary: Development of an integrated workflow for the identification of immune-relevant mutations, synthesis of derived peptides and clinical use of the corresponding neoantigens for novel immunisation strategies in colon and pancreas tumors. (English) / rank
 
Normal rank
Property / summary: Development of an integrated workflow for the identification of immune-relevant mutations, synthesis of derived peptides and clinical use of the corresponding neoantigens for novel immunisation strategies in colon and pancreas tumors. (English) / qualifier
 
point in time: 24 October 2021
Timestamp+2021-10-24T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 17:47, 24 October 2021

Project Q3304841 in Germany
Language Label Description Also known as
English
No label defined
Project Q3304841 in Germany

    Statements

    0 references
    8,373,248.91 Euro
    0 references
    10,466,561.14 Euro
    0 references
    80.0 percent
    0 references
    14 June 2017
    0 references
    31 May 2023
    0 references
    Miltenyi Biotec GmbH Niederlassung Teterow
    0 references
    17166 - Teterow
    0 references
    Entwicklung eines integrierten Workflows zur Identifikation von immunrelevanten Mutationen, Synthese der abgeleiteten Peptide und klinischen Nutzung der entsprechenden Neoantigene für neuartige Immunisierungsstrategien bei Colon- und Pankreas-Tumoren. (German)
    0 references
    Development of an integrated workflow for the identification of immune-relevant mutations, synthesis of derived peptides and clinical use of the corresponding neoantigens for novel immunisation strategies in colon and pancreas tumors. (English)
    24 October 2021
    0 references

    Identifiers

    DE_TEMPORARY_7626
    0 references